Our results could be also justified by the observation of Pasanen et al., who observed no difference between L1CAM serum levels of patients with an L1CAM-positive or L1CAM-negative endometrial carcinoma [18]. The gene discussed is L1CAM; the disease is endometrial carcinoma.